Startseite>>Signaling Pathways>> Cell Cycle/Checkpoint>> Proteolysis>>MMP-3 Inhibitor VIII

MMP-3 Inhibitor VIII (Synonyms: Matrix Metalloproteinase-3 Inhibitor VIII, Stromelysin-1 Inhibitor VIII)

Katalog-Nr.GC40624

Matrix metalloproteinases (MMPs) belong to a family of proteases that play a crucial role in tissue remodeling and repair by degrading extracellular matrix proteins to enable cell migration.

Products are for research use only. Not for human use. We do not sell to patients.

MMP-3 Inhibitor VIII Chemische Struktur

Cas No.: 208663-26-7

Größe Preis Lagerbestand Menge
500μg
77,00 $
Auf Lager
1mg
124,00 $
Auf Lager
5mg
385,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Matrix metalloproteinases (MMPs) belong to a family of proteases that play a crucial role in tissue remodeling and repair by degrading extracellular matrix proteins to enable cell migration. MMP-3 (also known as stromelysin-1) is thought to play a role in the vascular remodeling that occurs during aneurysm formation and may also be involved in wound repair, progression of atherosclerosis, and tumor initiation. MMP-3 inhibitor VIII is a cell permeable sulfonamide-based hydroxamic acid that binds to the active site of MMP-3 (Ki = 23 nM) and prevents its activity. This compound has also been shown to inhibit mouse macrophage metalloelastase MME/MMP-12 with an IC50 value of 13 nM.

Bewertungen

Review for MMP-3 Inhibitor VIII

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MMP-3 Inhibitor VIII

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.